🟢 Syncom Formulations is trading 10% up with no clear catalyst identified

Syncom Formulations is trading at ₹22.07, up 10.07%, with no clear cause identified in available reporting.

• A September 26 report said promoters waived their entitlement to the proposed FY26 dividend, reducing the amount payable to other shareholders; it did not link the announcement to the September 28 move.
• The proposed dividend and September 30 AGM were already known company events, not confirmed catalysts for the gain.
• No September 28 company-specific explanation or trading-activity details were found.